Oculis Holding
OCS
11 hedge funds and large institutions have $39.8M invested in Oculis Holding in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
22% more funds holding
Funds holding: 9 → 11 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less capital invested
Capital invested by funds: $40.9M → $39.8M (-$1.11M)
1.28% less ownership
Funds ownership: 9.26% → 7.98% (-1.3%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
ExodusPoint Capital Management
New York
|
+$600K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$183K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$48 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$1.52M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$32.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PBPIA
1
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
| $19.1M | – | – | – |
|
|
2
Aberdeen Group
Edinburgh,
United Kingdom
| $13.2M | -$1.52M | -127,610 | -10% |
|
|
NFGH
3
Nan Fung Group Holdings
Kai Tak,
Hong Kong
| $5.21M | – | – | – |
|
|
CLOS
4
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $1.14M | – | – | – |
|
|
ECM
5
ExodusPoint Capital Management
New York
| $602K | +$600K | +50,366 | New |
|
|
6
Bank of America
Charlotte,
North Carolina
| $205K | -$32.6K | -2,739 | -14% |
|
|
7
UBS Group
Zurich,
Switzerland
| $197K | +$183K | +15,403 | +1,404% |
|
8
Geode Capital Management
Boston,
Massachusetts
| $179K | – | – | – |
|
|
DCM
9
Dupont Capital Management
Wilmington,
Delaware
| $48 | – | – | – |
|
10
JP Morgan Chase
New York
| $12 | – | – | – |
|
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$48 | +4 | New |
|
OCS Hedge Fund Activity: Q2 2024 in Review
11 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Oculis Holding (OCS) for Q2 2024, worth a combined $39.8M — down 2.7% from $40.9M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new OCS positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was ExodusPoint Capital Management, opening a new position worth an estimated $600K. The largest seller was Aberdeen Group, cutting an estimated $1.52M.
- 11 institutional investors held Oculis Holding (OCS) as of Q2 2024, up from 9 in Q1 2024.
- Funds reported $39.8M of Oculis Holding stock for Q2 2024, down 2.7% quarter-over-quarter.
- 2 funds opened new Oculis Holding positions in Q2 2024 and 0 closed out, a net change of +2 holders.
- The largest Oculis Holding buyer in Q2 2024 was ExodusPoint Capital Management, an estimated $600K added.
- The largest Oculis Holding seller in Q2 2024 was Aberdeen Group, an estimated $1.52M sold.
Based on aggregated 13F filings for Q2 2024.